candesartan cilexetil has been researched along with triphenyltetrazolium in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lu, Q; Wong, PT; Zhu, YZ | 1 |
1 other study(ies) available for candesartan cilexetil and triphenyltetrazolium
Article | Year |
---|---|
Angiotensin receptor gene expression in candesartan mediated neuroprotection.
Topics: Analysis of Variance; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Body Weight; Brain Infarction; Functional Laterality; Gene Expression; Heart Rate; Infarction, Middle Cerebral Artery; Male; Neurologic Examination; Rats; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tetrazoles; Tetrazolium Salts; Time Factors | 2004 |